Literature DB >> 6776147

Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism.

V S Lim, C Henriquez, H Seo, S Refetoff, E Martino.   

Abstract

The main objective of this study was to determine whether the principal abnormality of thyroid function observed in patients with chronic renal failure, low serum triiodothyronine (T(3)) concentration, causes hypothyroidism at the tissue level. A partially nephrectomized (Nx) uremic rat model was developed and the following parameters of thyroid function were assessed: serum total thyroxine (TT(4)), total T(3) (TT(3)), and thyrotropin and liver T(3) content, and activity of two thyroid hormone-dependent enzymes, mitochondrial alpha-glycerophosphate dehydrogenase (alpha-GPD) and cytosol malate dehydrogenase (MDH). The results were compared to those of intact control (C), thyroidectomized (Tx), and nephrectomized-thyroidectomized (NxTx) littermates.Results expressed as mean+/-SEM showed that Nx rats had a fivefold increase in blood urea nitrogen, (112+/-20 mg/dl in Nx, and 22+/-1 mg/dl in C) and manifested all the changes of of thyroid function observed in uremic men, including a low serum TT(3) level (30+/-7 ng/dl in Nx and 50+/-6 ng/dl in C). In the liver, T(3) was significantly reduced (18+/-2 ng/total liver in Nx and 35+/-3 ng/total liver in C) as well as the activities of alphaGPD (8.8+/-1.0 and 16.1+/-1.5 DeltaOD/min per total liver in Nx and C, respectively) and MDH (6.3+/-1.6 and 12.6+/-2.2 U/total liver in Nx and C, respectively). The reduction in liver enzyme activities correlated significantly with the decrease in T(3) content. The changes in Tx rats were as expected, showing a profound reduction in serum hormone levels, liver T(3) content, and liver enzyme activities. Serum thyrotropin was markedly elevated to 2,390+/-212 ng/ml as compared to 703+/-61 in C and 441+/-87 ng/ml in Nx rats. The NxTx rats showed the combined effects of nephrectomy and thyroidectomy; blood urea nitrogen was elevated to 203, and serum levels of TT(4), TT(3), and thyrotropin were 0.4, <10, and 2,525, respectively. Total liver T(3) and alphaGPD and MDH were strikingly low; the corresponding values were 3.5, 2.4, and 2.5.l-triiodothyronine replacement (0.4 mug/100 g body wt/d) for 4 wk in the Nx rats resulted in significant increases in liver enzyme activities, alphaGPD and MDH rose by 70 and 60% over their respective basal values without alteration in the severity of azotemia. From these data, we conclude that the reduction of liver T(3) content in the uremic rats, accompanied by a decrease in alphaGPD and MDH activity, indicates the presence of hypothyroidism at the tissue level. Restoration of enzyme activities toward normal levels after T(3) administration provided further supporting evidence that the diminution in liver enzyme activity was causally related to tissue T(3) deficiency.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776147      PMCID: PMC371530          DOI: 10.1172/JCI109963

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation.

Authors:  V S Lim; S C Kathpalia; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1979-01       Impact factor: 5.958

2.  ALPHA-GLYCEROPHOSPHATE DEHYDROGENASE RESPONSE TO THYROXINE IN THYROIDECTOMIZED, THIOURACIL-FED AND TEMPERATURE-ADAPTED RATS.

Authors:  W R RUEGAMER; W W WESTERFELD; D A RICHERT
Journal:  Endocrinology       Date:  1964-12       Impact factor: 4.736

3.  INFLUENCE OF THYROID HORMONES ON L-ALPHA-GLYCEROPHOSPHATE DEHYDROGENASES AND OTHER DEHYDROGENASES IN VARIOUS ORGANS OF THE RAT.

Authors:  Y P LEE; H A LARDY
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

4.  Starvation-induced decreased sensitivity of resting metabolic rate to triiodothyronine.

Authors:  C Wimpfheimer; E Saville; M J Voirol; E Danforth; A G Burger
Journal:  Science       Date:  1979-09-21       Impact factor: 47.728

5.  Age-related reduction in response of hepatic enzymes to 3,5,3'-triiodothyronine administration.

Authors:  H L Schwartz; M A Forciea; C N Mariash; J H Oppenheimer
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

6.  The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats.

Authors:  J E Silva; T E Dick; P R Larsen
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

7.  Serum tests for measurement of thyroid function.

Authors:  N I Robin; S R Hagen; F Collaço; S Refetoff; H A Selenkow
Journal:  Hormones       Date:  1971

8.  Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects.

Authors:  L E Braverman; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

9.  Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure.

Authors:  G D Sievertsen; V S Lim; C Nakawatase; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1980-05       Impact factor: 5.958

10.  Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation.

Authors:  V S Lim; C Henriquez; G Sievertsen; L A Frohman
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

View more
  11 in total

1.  Importance of specific reference values for evaluation of the deteriorating thyroid function in patients with end-stage renal disease on hemodialysis.

Authors:  Toru Sanai; Ken Okamura; Tomoya Kishi; Motoaki Miyazono; Yuji Ikeda; Takanari Kitazono
Journal:  J Endocrinol Invest       Date:  2014-07-05       Impact factor: 4.256

2.  Effect of graded doses of tri-iodothyronine on ventricular myosin ATPase activity and isomyosin profile in young and old rats.

Authors:  W J Carter; W F Kelly; F H Faas; M E Lynch; C A Perry
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

3.  Pituitary glycoprotein hormones in chronic renal failure: evidence for an uncontrolled alpha-subunit release.

Authors:  G Medri; C Carella; V Padmanabhan; C M Rossi; G Amato; N G De Santo; I Z Beitins; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

4.  Effects of clofibrate on salt loading-induced hypertension in rats.

Authors:  Antonio Cruz; Isabel Rodríguez-Gómez; Rocío Pérez-Abud; Miguel Ángel Vargas; Rosemary Wangensteen; Andrés Quesada; Antonio Osuna; Juan Manuel Moreno
Journal:  J Biomed Biotechnol       Date:  2010-10-14

5.  Starvation and hypothyroidism exert an overlapping influence on rat hepatic messenger RNA activity profiles.

Authors:  F E Carr; S Seelig; C N Mariash; H L Schwartz; J H Oppenheimer
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  A longitudinal evaluation of thyroid function in critically ill surgical patients.

Authors:  G P Zaloga; B Chernow; R C Smallridge; R Zajtchuk; K Hall-Boyer; R Hargraves; C R Lake; K D Burman
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

7.  Evidence against benefit from replacement doses of thyroid hormones in nonthyroidal illness (NTI): studies using turpentine oil-injected rat.

Authors:  I J Chopra; T S Huang; R Boado; D H Solomon; G N Chua Teco
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

8.  Abnormal cation transport in uremia. Mechanisms in adipocytes and skeletal muscle from uremic rats.

Authors:  W Druml; R A Kelly; R C May; W E Mitch
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

9.  Hepatic messenger ribonucleic acid activity profiles in experimental azotemia in the rat. Relationship to food intake and thyroid function.

Authors:  W B Kinlaw; H L Schwartz; C N Mariash; C Bingham; F E Carr; J H Oppenheimer
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  [Disorders of hormone metabolism in chronic uremia].

Authors:  M Weissel; H K Stummvoll
Journal:  Klin Wochenschr       Date:  1983-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.